FDA approves Lilly's Mounjaro to reduce cardiovascular risk in type 2 diabetes patients
.thumb.png.ea12d62fcb43a79b1d7a7a4664107cbc.png)
Entry posted by ADMIN
5 views
FDA approves Lilly’s Mounjaro to reduce cardiovascular risk in type 2 diabetes patientsThe U.S. Food and Drug Administration has approved Eli Lilly’s Mounjaro to minimise the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular...
0
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.